GlassScriptPhysician profile
Howard S Landsman
NPI 1245227826
$1,719.03
in general payments reported to CMS, 2019-2025
17 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $189 · 2020: $29.43 · 2021: $168 · 2022: $162 · 2023: $397 · 2024: $471 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,169.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $480.12 | 2022-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $446.41 | 2019-2025 | Dupixent |
| Genzyme Corporation | $129.44 | 2023-2024 | |
| Glaxosmithkline, LLC. | $110.41 | 2023-2024 | Nucala |
| Innovation Technologies INC | $107.01 | 2021 | |
| Optinose US, INC. | $94.35 | 2019-2025 | |
| Intersect Ent, INC. | $88.54 | 2019-2021 | |
| Stryker Corporation | $72.36 | 2019-2025 | Xpress Loprofile |
| Integra Lifesciences Corporation | $61.36 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Alk-Abello, INC | $26.29 | 2019 | |
| Aerin Medical INC. | $18.40 | 2023 | |
| Merck Sharp & Dohme LLC | $16.09 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $14.84 | 2025 | Tezspire |
| Fiagon Na LLC | $14.58 | 2020 | |
| Paratek Pharmaceuticals, INC. | $13.70 | 2025 | Xhance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.38 | 2019 | |
| Acclarent, INC | $11.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Landsman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.